Search Videos by Topic or Participant
Browse by Series:

Important Considerations in Iron Chelation Therapy

Insights From:Thomas D. Coates, MD
Published: Tuesday, Oct 13, 2015

 
Any patient receiving regular blood transfusions will need to have the excess iron in their body removed, says Thomas D. Coates, MD. For patients who receive iron chelation therapy, careful monitoring is critical, as renal and neurologic side effects can occur. Iron chelation therapy can also result in low white blood cell counts, adds Coates. In children, it is important to recognize that iron is essential to their growth and development.
 
In Coates’ opinion, regulating the dose of an iron chelating agent should be based more on tolerance for the medication than on the body’s iron levels. Poor adherence remains an issue with these agents, adds Coates.
 
Slider Left
Slider Right

 
Any patient receiving regular blood transfusions will need to have the excess iron in their body removed, says Thomas D. Coates, MD. For patients who receive iron chelation therapy, careful monitoring is critical, as renal and neurologic side effects can occur. Iron chelation therapy can also result in low white blood cell counts, adds Coates. In children, it is important to recognize that iron is essential to their growth and development.
 
In Coates’ opinion, regulating the dose of an iron chelating agent should be based more on tolerance for the medication than on the body’s iron levels. Poor adherence remains an issue with these agents, adds Coates.
 
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta OnlineDec 21, 20182.0
Community Practice Connections™: 2nd Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesDec 30, 20182.0
Publication Bottom Border
Border Publication
x